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a b s t r a c t
Tigecycline resistance has been attributed to ramAoverexpression and subsequent acrAupregulation. The
ramA locus, originally identiﬁed in Klebsiella pneumoniae, has homologues in Enterobacter and Salmonella
spp. In this study,we identify in silico that the ramR binding site is also present in Citrobacter spp. and that
Enterobacter,Citrobacter andKlebsiella spp. share key regulatory elements in the control of the romA–ramA
locus. RACE (rapid ampliﬁcation of cDNA ends) mapping indicated that there are two promoters from
which romA–ramA expression can be regulated in K. pneumoniae. Correspondingly, electrophoretic bind-
ing studies clearly showed that puriﬁed RamAandRamRproteins bind to both of these promoters. Hence,
there appear to be two RamR binding sites within the Klebsiella romA–ramA locus. Like MarA, RamA bindscrA
igecycline
the promoter region, implying that it might be subject to autoregulation. We have identiﬁed changes
within ramR in geographically distinct clinical isolates of K. pneumoniae. Intriguingly, levels of romA and
ramA expression were not uniformly affected by changes within the ramR gene, thereby supporting the
dual promoter ﬁnding. Furthermore, a subset of strains sustained no changes within the ramR gene but
which still overexpressed the romA–ramA genes, strongly suggesting that a secondary regulator may
control ramA expression.
 PublCrown Copyright © 2011
. Introduction
Klebsiella pneumoniae is a major nosocomial pathogen that
auses both community- and hospital-acquired infections.
trains with chromosomal and/or plasmid-mediated resistance
echanisms coupled with efﬂux/inﬂux-related mutations are
eing increasingly identiﬁed [1–3]. The continued antimicrobial
hallenge of K. pneumoniae has precipitated the emergence of
lones harbouring a plethora of resistance mechanisms to clini-
ally relevant antibiotics (e.g. ﬂuoroquinolones, third-generation
ephalosporins andcarbapenems) andemergingpandrug-resistant
lones have left few therapeutic strategies available to combat this
athogen [4].
Tigecycline is a new glycylcycline with substantial anti-Gram-
egative activity that has been introduced for the treatment
f community-acquired Gram-negative infections caused by
xtended-spectrum -lactamase-producing K. pneumoniae and
scherichia coli [5]. A recent study has shown that tigecycline is
ffective against pandrug-resistant K. pneumoniae and Enterobac-
∗ Corresponding author. Tel.: +44 28 9097 5831; fax: +44 28 9097 2695.
E-mail address: t.schneiders@qub.ac.uk (T. Schneiders).
924-8579 Crown Copyright © 2011 Published by Elsevier B.V. on behalf of International
oi:10.1016/j.ijantimicag.2011.02.012ished by Elsevier B.V. on behalf of International Society of Chemotherapy.
ter spp. Tigecycline is able to evade the classical mechanisms
that confer resistance to tetracycline and minocycline, such as
Tet(A–E)-mediated efﬂux and ribosomal protection conferred by
Tet(M) [5]. However, tigecycline appears to be vulnerable to efﬂux
by chromosomally encoded efﬂux pumps [6–10].
Studies into tigecycline resistance in members of the
Enterobacteriaceae have shown that it is mediated via upreg-
ulation of efﬂux pumps that are controlled by certain regulatory
loci [6–8,10]. For instance, several studies have demonstrated that
tigecycline resistance results from upregulation of AraC family
transcriptional regulators such as MarA or RamA, which in turn are
linked to increasedexpressionof theAcrABefﬂuxpump [6,7,10,11].
This pump not only functions as a clinically relevant drug exporter
but has also been demonstrated to affect signiﬁcantly the virulence
potential of the bacterium [12,13]. The AcrAB efﬂux pump is locally
controlled by the transcriptional repressor AcrR [14]. However,
transcription factors such as RamA and MarA are able to override
AcrR-mediated repression and upregulate expression of the AcrAB
Open access under CC BY license.efﬂux pump [6,7,10,11]. Accordingly, strains with wild-type AcrR
and increased RamA or MarA expression are linked to increased
AcrAB levels [11]. Whether levels of AcrA upregulation in the
absence of acrR mutations are as signiﬁcant as those seen when
acrR is mutated is not clear.
 Society of Chemotherapy. Open access under CC BY license.
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Table 1
Primer sequences used in the study.
Primer Sequence
ramAF 5′-AGCCTGGGGCGCTATATT-3′
ramAR 5′-GTGGTTCTCTTTGCGGTAGG-3′
romAF 5′-GAAGCGTAACCAGACGCTGT-3′
romAR 5′-CTGGTCATACTGCCCGTTCT-3′
ramRF 5′-AACTGCAGTCGTCAAGACGATTTTCAATTTT-3′
ramRR 5′-AAAAGTACTAGTGTTTCCGGCGTCATTAG-3′
acrRF 5′-TTAAGCTGACAAGCTCTCCG-3′
acrRR 5′-ACGTAACCTCTGTAAAGTCAT-3′
pIF 5′-GGGCCAGTTTTCTGTT-3′
pIR 5′-ATAGTATCAATCACCTGAGC-3′
pIIF 5′-CTACTTTTTTCCTCACGCAG-3′
pIIR 5′-CCCTGCGGCGCCTTACCA-3′
16SF 5′-GTTACCCGCAGAAGAAGCAC-3′
′ ′0 R. Rosenblum et al. / International Jour
RamA is a member of the AraC/XylS family and is closely related
o the MarA and SoxS proteins [15]. The ramA locus is only found in
lebsiella, Salmonella, Enterobacter and Citrobacter spp.; the genetic
rganisation in Salmonella differs from the others owing to lack of
he romA gene. Like MarA, increased ramA expression is linked to
pregulation of the AcrAB efﬂux pump, which confers a multidrug-
esistant phenotype to a variety of different antibiotic classes
7,10,11,16]. This phenotype is mediated exclusively through the
crAB gene, as ramA overexpression in an acrAB-deleted strain does
ot produce a similar phenotype [11].
Expression of the ramA gene is controlled at a transcriptional
evel. Studies both in Salmonella enterica serovar Typhimurium
17] and K. pneumoniae [16] have identiﬁed a tetR-like gene, called
amR, that lies upstream of the ramA gene and acts as its repressor
Fig. 1). Of note, the stop codon of the ramR gene overlaps the start
odon of the ybdF gene, implying that regulation of these genes
s very likely linked. Studies both into S. Typhimurium [17] and K.
neumoniae [16] have reported that ramR mutations are directly
inked to ramA overexpression. Both in Salmonella and Klebsiella,
ioinformatic analyses suggest that the RamR protein binds a
alindromic sequence that is either overlapping or downstream
f the –10 sequence of the ramR gene [16,17]. In K. pneumoniae
nd Enterobacter spp., the genomic organisation of ramR, its
orresponding palindromic binding sites and ramA is conserved
ompared with Salmonella, although these bacteria also harbour
he romA gene (Fig. 1). Mutations within the ramR gene have been
hown to result in ramA upregulation [16,17], however the effect
f this derepression on the surrounding genes within the locus, i.e.
omA, is not known.
In studies involving clinical strains, ramA upregulation is not
ormally the sole mechanism of resistance but appears to act in
ombination with other mutations, e.g. cefuroxime-resistant iso-
ates also showed a decrease in levels of the outer membrane
rotein OmpK35 [18], and in ﬂuoroquinolone-resistant isolates
pregulation of the ramA gene was in association with target-
peciﬁc mutations in the topoisomerase genes (e.g. gyrA and parC)
nd mutations within acrR, the repressor of the acrAB efﬂux pump
11]. Hence, the aimsof this studywere to elucidate the genetic reg-
lation of the ramA locus and whether its overexpression is always
inked to changes within the ramR gene.
. Materials and methods
.1. Clinical isolates
All isolates were identiﬁed as K. pneumoniae and were isolated
rom intensive care wards in hospitals within Chile, Turkey and
akistan from 2006–2008. Three strains from Singapore charac-
erised in a previous study [11] as well as the original strains (Ecl8
nd Ecl8Mdr1) described by George et al. [15] were also included.
ther strains used as controls in this study were: for validation
f the AcrA Western blot analyses, AG100A (deleted for acrA) and
G100B (deleted for acrR, AcrA-overexpresser); and for validation
f the ramA reverse transcription polymerase chain reaction (RT-
CR), TS67 (deleted for ramA) and TS68 (deleted for ramR) [19]. The
utants TS67 and TS68 were generated from K. pneumoniae Ecl8
sing a modiﬁed protocol as described by Merlin et al. [20].
.2. Minimum inhibitory concentration (MIC) testingMICs of tigecycline (gift from Wyeth Pharmaceuticals) for the
linical isolates were determined and interpreted according to
ritish Society for Antimicrobial Chemotherapy (BSAC) protocols
21]. Strains exhibiting tigecycline MICs ≤1g/mL and >2g/mL
ere classed as sensitive and resistant, respectively.16SR 5 -CTACGCATTTCACCGCTACA-3
ramAR1 5′-TTGCAGATGCCATTTCGA-3′
ramAR2 5′-TATCATCAATACGCAGCG-3′
ramAR3 5′-GGGGTACCATAGTATCAATCACCTGAGC-3′
2.3. Mapping the transcriptional start site of the ramA locus
The transcriptional start site of the ramA locus was mapped
according to the manufacturer’s instructions using the 5′ RACE
(rapid ampliﬁcation of cDNA ends) system (Invitrogen, Carls-
bad, CA). Brieﬂy, 0.5g of RNA extracted at mid log phase was
reverse transcribed into ﬁrst-strand cDNA, which was then ter-
minal deoxynucleotidyl transferase (TdT)-tailed. Subsequently, the
TdT-tailedcDNAwasampliﬁedbyPCRandwasassessed forpositive
PCR products. A second round of ampliﬁcation using nested gene-
speciﬁc primers (Table 1) and Abridged Universal Ampliﬁcation
Primer (AUAP)was performed prior to the resulting products being
subcloned into pGEM®-T Easy vector (Promega, Southampton, UK)
for sequencing.
2.4. Gene expression analyses using RT-PCR
RT-PCR was performed to assess the expression levels of the
ramA and romA genes. RNA samples were extracted from the dif-
ferent clinical isolates at mid log phase [optical density at 600nm
(OD600) 0.5–0.8] using TRIzol®. Total RNAwas digestedwith DNase
I to ensure the removal of contaminating genomic DNA prior to
cDNA synthesis. For cDNA synthesis, a SuperScript® VILOTM cDNA
Synthesis Kit (Invitrogen) was used. Brieﬂy, 300ng of DNase I-
treated total RNA was converted to cDNA and was used in PCRs
with gene-speciﬁc primers shown in Table 1. A 1 in 10 cDNA dilu-
tion was used for ampliﬁcation of the 16S gene. The resulting PCR
products were subjected to electrophoresis on a 1.5% agarose gel.
Densitometric analyses using Multi Gauge FujiFilm software of the
gel bands were performed and normalised to 16S expression. The
fold increase in ramA expression relative to the sensitive strain Ecl8
(ramA non-expresser) is shown in Fig. 2A.
2.5. Electrophoretic mobility shift assay (EMSA)
The romA–ramApromoter regionswere ampliﬁed and subjected
to EMSA with both puriﬁed RamA and RamR proteins. Puriﬁed
RamA and RamR proteins were extracted from recombinant pET
constructs containing the ramA and ramR genes using metal chela-
tion chromatography on nickel/nitrilotriacetate superﬂow agarose
(QIAGEN, Crawley, UK). Brieﬂy, end-labelled (using [-32P] ATP;
Perkin Elmer, Boston, MA) PCR products were incubated with
increasing concentrations (200nM and 400nM) of RamA or RamR
inbindingbuffer (125mMTris–Cl, 250mMKCl, 5mMdithiothreitol
[DTT], 160ng of salmon sperm DNA and 25% glycerol). The com-
plexes were run on 5% native polyacrylamide gel electrophoresis
(PAGE) gels for 2.5h. The gel was then dried and exposed to the
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ll promoter changes are in grey, with those hypothesised to be associated with ram
hosphor screen for imageanalysis. Toconﬁrmthat the interactions
etween RamA or RamR and the promoter regions were speciﬁc,
ompetition experiments with bovine serum albumin (BSA) as a
egative control and with cold promoter were also performed.
.6. Mutations within the promoter regions and the ramR and
crR genes
For those strainswhere ramA expressionwas elevated, the ramR
nd acrR genes and the pI/pII promoter regions were ampliﬁed
sing theprimers shown inTable 1. TheBigDyeTM reaction (Applied
iosystems,Warrington, UK)was set up prior to the products being
equenced at the Genomics Core Facility in Belfast City Hospital
Belfast, UK).
.7. Western blot analyses
Levels of AcrA were determined by Western blot analyses as
escribed previously by Schneiders et al. [11]. Brieﬂy, cultureswere
rown to mid log phase (OD600 ca. 0.6–0.7) prior to protein extrac-
ion using sonication. Then, 15g of total protein was loaded onto
10% NuPAGE® gel (Invitrogen) prior to transfer to a nitrocellulose
embrane as per the manufacturer’s instructions. The blots werer in Salmonella, Klebsiella, Enterobacter and Citrobacter spp. (B) Regulatory elements
by arrows. The two putative promoters are depicted as pI and pII. The transcription
he translation start site of both romA and ramA is indicated in bold and superscript.
erexpression in grey and with an asterisk. IR, intergenic region.
hybridised with the primary antibody anti-AcrA (kind gift from
H. Zgurskaya, University of Oklahoma, Norman, OK) (1:40000)
overnight at 4 ◦C. The secondary antibody IRDye-800 goat anti-
rabbit IgG (Li-Cor Biosciences, Lincoln, NE) was incubated with the
blots for1hat roomtemperatureand themembraneswere scanned
using the Odyssey Infrared Imaging system, which is based on near
infraredﬂuorescencedetection. Themembranewas scanned in two
channels at 700nM and 800nM, which detects the green and red
channels, respectively. All images were quantiﬁed using the read-
ing from the 800nM channel. Analysis of band intensities to assess
AcrA levels was performed using the Odyssey software v3 (Li-Cor
Biosciences). Levels of AcrA protein of all test strains were com-
pared against the sensitive K. pneumoniae strain Ecl8 to report a
relative fold increase inAcrA levels. BothAG100AandAG100Bwere
also used as controls in the AcrA Western blots.
3. Results3.1. Minimum inhibitory concentrations
The MIC50 and MIC90 values (MICs for 50% and 90% of the
organisms, respectively) of tigecycline, minocycline, tetracycline,
ciproﬂoxacin and ceftazidime against the strains are shown in
42 R. Rosenblum et al. / International Journal of Antimicrobial Agents 38 (2011) 39–45
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able 2. Of the 157 strains tested, 24 were resistant to tigecycline
ased on the BSAC breakpoint criteria [21]. MICs to tigecycline
enerally ranged from 0.25g/mL to 4g/mL. Minocycline and
etracyclineMIC90 valueswere128g/mLand>128g/mL, respec-
ively; however, cross-resistance to tigecycline was not observed,
onsistentwithprevious surveydata [22]. Tigecycline-resistant iso-
ates exhibited cross-resistance to ceftazidime and ciproﬂoxacin.
.2. Bioinformatic analyses for RamR binding sites in Klebsiella
neumoniae (accession no. NC 009648), Citrobacter koseri
accession no. NC 009648) and Enterobacter sp. 638 (accession
o. NC 009648)
In S. Typhimurium, ramR has been shown to function as
ts cognate negative regulator [17]. Given the similarities in
he genomic organisation of the ramR and romA–ramA loci
etween Klebsiella, Enterobacter, Citrobacter and Salmonella,
e sought to conﬁrm whether ramR controlled the expres-ion of the romA–ramA locus directly in Klebsiella and whether
ther accessory binding sites existed for RamR within the
omA–ramA locus. Bioinformatic analyses using ClustalW
http://www.ebi.ac.uk/Tools/clustalw2/index.html) showed that
he palindromic binding sites identiﬁed for RamR in Salmonella
able 2
inimum inhibitory concentrations (MICs) for 157 clinical isolates.
Antimicrobial agent MIC (g/mL)
MIC50 MIC90
Ciproﬂoxacin 128 >128
Ceftazidime >128 >128
Tetracycline >128 >128
Minocycline 32 128
Tigecycline 1 2
IC50/90, MIC for 50% and 90% of the organisms, respectively.e clinical strains. Levels of romA and ramA were normalised to K. pneumoniae Ecl8
ses in the AcrA levels were quantiﬁed after comparisons with a wild-type sensitive
spp. are conserved within the intergenic region between the
ramR and romA coding sequences of K. pneumoniae, Enterobacter
and Citrobacter spp. (Fig. 1A). There appeared to be no perfect
palindromic site for RamR upstream of the ramA gene. Thus, we
surmised that regulation of the romA–ramA locus mediated by
RamR must occur via the palindromic sequence that lies upstream
of the romA gene.
3.3. RACE mapping
The transcriptional start site of ramA as determined by RACE
mapping is shown in Fig. 1B. The transcriptional start site (hereby
called pII) (Fig. 1B) for ramA was found upstream of the romA stop
codon, which implies that romA and ramA are part of an operon
and are likely co-transcribed in K. pneumoniae. The transcriptional
start site mapped corresponds with our previous observation that
two transcripts sized ca. 0.6 kb and ca. 0.9 kb were obtained with
Northernblotting. The larger transcriptmust correspond to thepro-
moter that lies upstream of the romA gene. The presence of the
pII promoter also suggests that ramA expression can be modulated
independently of romA. Correspondingly, this differential regula-
tion is evident in the differing levels of transcription of the romA
and ramA genes as shown in Fig. 2A.
3.4. Electrophoretic mobility shift assay
Bioinformatic analyses indicate the presence of a putative but
conserved palindromic binding site for RamR within the pI region.
However, no such site could be observed for the pII promoter. We
also wondered whether RamA, like other similar regulators (i.e.
MarA), autoregulates itself by binding to its own promoter region.
The intergenic regions, designated pI and pII, bound both puriﬁed
RamR and RamA proteins (Fig. 3A). The interactions of the pI and
pII promoter regionswith the RamAandRamRproteinswere found
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cig. 3. Electrophoretic mobility shift assay (EMSA) of the promoter regions with pur
o the pI and pII promoter regions. (B) pII* represents the region underlined (dashe
o be speciﬁc, as no shifts were observed with BSA alone (Fig. 3A)
nd addition of cold promoter was able to reduce binding of the
roteins to the labelled probe (data not shown). Of note, the frag-
ent of DNA (pII*) that contained no transcriptional signals was
ound not to bind either RamA or RamR (Fig. 3B). As indicated
reviously, the pI promoter has a conserved RamR binding site
hat is required for RamR-mediated control. However, the lack of
similar or identical RamR binding site (by bioinformatic analy-
es) indicates that RamR-mediated regulation of the pII promoter
ay be mediated via a more degenerate palindromic binding site.
ccordingly, bioinformatic analyses using the EMBOSS Pairwise
lignment Tool (http://www.ebi.ac.uk/Tools/emboss/align/) of the
II promoter region implies that there is a putative but degenerate
alindromic site upstream of the ramA gene (Fig. 1A).
.5. DNA mutations in the promoter regions pI and pII and the
amR and acrR genes
.5.1. Mutations within the ramR gene and levels of romA and
amA expression
Of the 24 strains that were resistant or intermediately sus-
eptible to tigecycline, only 10 harboured mutations within the
amR gene. Changes within the ramR gene were found in both
he DNA- and ligand-binding domains of the protein (prediction
ased on PSIPREDv3 [23]), suggesting that there are no muta-
ional hotspots within ramR, although the majority of changes
ere clustered within the ligand-binding domain. As previously
uspected, not all of the changes observed within RamR resulted
n ramA expression, e.g. changes H186N and A187E observed in
S202 and change E41K in TS215 did not result in ramA overex-
ression. The change I141T was observed in four of the isolates
ested (Ecl8, Ecl8Mdr1, TS262 and TS293) (Table 3A). Since this
hange is also found in the sensitive Klebsiella strain Ecl8 it is likely
hat it is not associated with ramA overexpression. In addition,
trains TS173, TS221, TS257 and TS259 did not harbour changes
ithin the ramR gene (Table 3A) and/or the intergenic regions
ut still overexpressed ramA (Fig. 2A). Several strains exhibiting
ICs≥4g/mL were found to overexpress ramA but not to har-
our any changes within the ramR gene. Interestingly, levels of
amA expression between those strains that harboured changes
ithin ramR were not higher than those strains that sustained no
hanges within the gene. In addition, transcriptional levels of theamA or RamR proteins. (A) EMSA showing the binding of puriﬁed RamR and RamA
) in Fig. 1B.
romA gene did not appear to be linked to ramA expression (Fig. 2A),
although increased expression of romA was generally associated
with strains that harboured changeswithin the ramR gene (Fig. 2A).
Ideally, complementation studies with wild-type ramR would have
beenperformedtoconﬁrmwhether the ramR changesweredirectly
associated with ramA overexpression. However, this was not pos-
sible owing to the multidrug-resistant proﬁles of the different
strains.
3.5.2. Promoter (pI and pII) mutations
Unlike previous reports, the majority of the clinical isolates
did not harbour any changes within the pI promoter. However,
the lack of promoter-associated changes linked to increased ramA
expression is not unique to this cluster of isolates, as the origi-
nal ramA-overexpressing strain Ecl8MdrI (as reported by George
et al. [15]) also does not harbour any changes within the ramR
gene, the palindrome or the −10 and −35 hexamers at the pI
promoter. Only one strain (TS170), which sustained a change
within the palindromic sequence (C→T, recognised by RamR) but
harboured no changes within the ramR gene, was found. Corre-
spondingly, TS170 exhibited a small increase in ramA expression
(Fig. 2A). Several changes associated with the pII promoter region
were located downstream of the second putative palindrome but
upstream of the RACE-mapped transcriptional start site of ramA
(Fig. 1B). Three changes (T206C, G229A and A235T) were con-
sistently identiﬁed in four strains (S7, TS152, TS165 and TS261)
(Table 3B), all of which overexpressed ramA. Of these strains,
only S7 and TS261 harboured no changes within the ramR gene
(Table 3A).
3.5.3. Mutations within the acrR gene and levels of AcrA protein
Of the 27 strains tested, 9 sustained changes within the acrR
gene. Of these changes, only two (T5N and L214F) have been pre-
viously documented [11]. The other nucleotide substitution, but
not amino acid change (E147E), was found in a region previously
shown to be implicated in AcrA overexpression. One new silent
change (P155P, CCC→CCT) was observed. Given that most of the
changes observed were silent, it is unlikely that they would have
contributedsigniﬁcantly toAcrA levels. StrainsTS165, TS173, TS257
and TS293, which signiﬁcantly overexpressed ramA, appear not to
produce greater levels of the AcrA protein (Fig. 2B).
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Table 3A
Association between RamR and AcrR changes and tigecycline minimum inhibitory concentration (MICs).
Strain RamR AcrR Tigecycline MIC (g/mL) Origin
S7 No change [11] 8 Singapore
S28 15 nt  (558–573bp) [11] 2 Singapore
S29 7 nt insertion at nt position 561 [11] 16 Singapore
TS152 T119P No change 4 Turkey
TS165 T119P GAG440GAA (E147E) 4 Turkey
TS170 No change No change 2 Turkey
TS173 No change No change 2 Turkey
TS184 No change No change 4 Turkey
TS202 H186N, A187E No change 2 Chile
TS215 E41K CCC465CCT (P155P) 4 Chile
TS221 No change GAG440GAA (E147E) 2 Chile
TS238 A19V GAG440GAA (E147E) 4 Pakistan
TS240 No change CCC465CCT (P155P) 4 Pakistan
TS245 No change TTG641TTT (L214F) 4 Pakistan
TS248 No change ACC14AAC (T5N) 4 Pakistan
TS250 No change GAG440GAA (E147E) 4 Pakistan
TS251 No change No change 8 Pakistan
TS257 No change No change 16 Pakistan
TS259 No change No change 2 Pakistan
TS261 No change GAG440GAA (E147E) 4 Pakistan
TS262 I141T No change 4 Pakistan
TS267 No change No change 4 Pakistan
5CCU
nge
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dTS293 I141T CCC46
TS308 W94Stop No cha
t, nucleotide.
. Discussion
Recent studies have linked antibiotic resistance, particularly
igecycline resistance, to increased expression of the ramA gene.
n this study, we identiﬁed in silico that key regulatory features
f the ramA locus are conserved amongst Klebsiella, Enterobacter,
itrobacter and Salmonella spp.
This work also shows that both the RamR and RamA
roteins bind the pI and pII promoters speciﬁcally, imply-
ng the presence of recognition sites for both proteins within
hese promoter regions. Like other orthologous systems, such
s MarRAB and SoxRS [24], binding of puriﬁed RamA to
he pI and pII promoters indicates that ramA autoregulates
ts own expression. In addition, RamR appears to be able
o bind regions that either contain a perfect palindrome or
ore degenerate palindromic sites (Figs. 1A and 3A). Other
etR-like regulators have been shown to regulate via palin-
romic binding sites that are identiﬁed as lower-afﬁnity binding
ites owing to key differences in the palindromic binding
equence.
able 3B
hanges observed within the pI and pII promoter regions.
Strain pI pII
S7 T141C T206Ca
S28 – –
S29 – –
TS 152 – T206C, G229A, A235T
TS 165 – T206C, G229A, A235T
TS 170 T141C, C56Tb –
TS 243 T141C –
TS 245 T141C –
TS 248 T141C –
TS 250 T141C –
TS 251 T141C –
TS 257 T141C –
TS 261 T141C T206C, G229A, A235T
a Bold indicates a change within the putative – 35 hexamer sequence upstream
f the romA gene.
b Indicates a recurring change that occurs in clinical isolates from geographically
istinct locations.(P155P) 4 Pakistan
4 Pakistan
Thepresent results showthat regulationof the romA–ramA locus
is not entirely identical to that observed in Salmonella as there
are two promoters within the romA–ramA locus. The presence of
these two promoters supports the possibility that the romA–ramA
genes can be regulated independently of each other or as part of an
operon (Fig. 2A). Consistentwith this genetic arrangement, changes
were identiﬁed within the pI and putative pII promoter regions in
the ramA-overexpressing strains (Table 3B). Interestingly, levels of
romA and ramA expression are not linked, supporting the ﬁnding
that two different promoters control regulation of the romA–ramA
locus (Fig. 2A).
We chose to extend the molecular ﬁndings by determin-
ing the regulation of ramA expression in clinical isolates that
were resistant or intermediately susceptible to tigecycline. The
results demonstrate that in geographically diverse isolates of
K. pneumoniae, 18 isolates exhibited tigecycline MICs≥4g/mL
(Table 3A). A notable example is strain TS257, which exhibits
a tigecycline MIC of 16g/mL, and where no mutations were
observed within the ramR–romAramA locus but it still overex-
pressed the ramA gene. Two key observations arise from these
data: ﬁrst, ramA is not always associated with ramR-mediated
derepression; and second, decreased tigecycline susceptibility
is not always associated with ramA expression. We also did
not observe any signiﬁcant mutations within the promoter
regions, as has been observed previously [16,17]. An interest-
ing point is that the isolates in this study pre-date the use
of tigecycline in the relevant hospitals, which underscores the
likelihood that most antibiotics have the propensity to select
for changes that result in ramA overexpression, a similar sit-
uation that is noted for the marRAB and soxRS systems [24].
The lack of a direct association between ramA and acrA expres-
sion has been noted previously [25] and supports the current
data.
Overexpression of transcriptional regulators such as RamA trig-
gers the expression of a multitude of genes that confer pleiotropic
phenotypes [26] (Schneiders, unpublished data). Given the var-
ied bacterial response that is mounted with ramA overexpression,
we should consider the broader implications of these intrinsic
resistance mechanisms in the development and persistence of
antimicrobial resistance.
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